Palvella Therapeutics (PVLA) Share-based Compensation (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.00% |
| Dec 31, 2025 | 16.42% |
| Sep 30, 2025 | 24.91% |
| Jun 30, 2025 | 30.99% |
| Mar 31, 2025 | 308.21% |
| Dec 31, 2024 | 34.67% |
| Sep 30, 2024 | -8.29% |
| Jun 30, 2024 | 48.63% |
| Mar 31, 2024 | 106.36% |
| Dec 31, 2023 | -337.58% |
| Sep 30, 2023 | -7.82% |
| Jun 30, 2023 | 18.55% |
| Mar 31, 2023 | -6.85% |
| Dec 31, 2022 | -2.57% |
| Sep 30, 2022 | -25.13% |
| Jun 30, 2022 | 10.44% |
| Mar 31, 2022 | -10.76% |
| Dec 31, 2021 | -3.65% |
| Sep 30, 2021 | 3.32% |
| Jun 30, 2021 | 10.59% |
| Mar 31, 2021 | 2.13% |
| Dec 31, 2020 | -15.90% |
| Sep 30, 2020 | 12.85% |
| Jun 30, 2020 | -3.59% |
| Mar 31, 2020 | 15.17% |
| Dec 31, 2019 | -26.61% |
| Sep 30, 2019 | 4.55% |
| Jun 30, 2019 | 12.56% |
| Mar 31, 2019 | 0.94% |
| Dec 31, 2018 | -2.44% |
| Sep 30, 2018 | -3.03% |
| Jun 30, 2018 | 34.56% |
| Mar 31, 2018 | -7.38% |
| Dec 31, 2017 | 66.78% |
| Sep 30, 2017 | 16.09% |
| Jun 30, 2017 | -25.55% |
| Mar 31, 2017 | 57.11% |
| Dec 31, 2016 | 7.30% |
| Sep 30, 2016 | -27.09% |
| Jun 30, 2016 | 66.09% |
| Mar 31, 2016 | 197.78% |
| Dec 31, 2015 | -211.54% |
| Sep 30, 2015 | 26.02% |
| Jun 30, 2015 | -13.83% |